Apta-1 improves survival rate and blood circulation in a clinical model relevant for sepsis
2017-07-28
Aptahem (publ) can today announce a positive outcome from a study performed in collaboration with Hooke Laboratories (US). The study evaluated the pharmaceutical candidate Apta-1 in a clinically relevant model for sepsis which showed a significant improvement in survival...
Read More